Variables | COPD patients (n = 213) |
---|---|
Male, n (%) | 193 (90.6) |
Age, years (mean ± SD) | 73.1 ± 8.4 |
BMI (mean ± SD) | 23.57 ± 4.11 |
Cigarette smoking, n (%) | |
Current smoker | 80 (37.5) |
Ex-smoker | 113 (53.1) |
Never smoker | 20 (9.4) |
Comorbidities, n (%) | |
Heart failure | 17 (7.98) |
Coronary artery disease | 54 (25.35) |
Pulmonary hypertension | 28 (13.15) |
Lung cancer | 3 (1.4) |
Anxiety/depression | 9 (4.2) |
Osteoporosis | 12 (5.63) |
Malnutrition (BMI < 20) | 38 (17.84) |
Diabetes mellitus | 34 (15.96) |
OSA | 8 (3.76) |
Normocytic anemia | 26 (12.2) |
Lung fibrosis | 14 (6.57) |
Charlson comorbidity index score; median (IQR) | 5 (4–6) |
Hemogram values; median (IQR) | |
Leukocyte count | 7800 (6500–9400) |
Neutrophil, % | 62.9 (54.3–71.1) |
Eosinophil, % | 2.2 (1.0–4.0) |
Pulmonary function tests; median (IQR) | |
Post bronchodilator FEV1/FVC, % | 56 (40.2–72.2) |
Post bronchodilator FEV1, % | 56 (47–63.4) |
COPD subtypes, n (%) | |
GOLD I | 29 (13.6) |
GOLD II | 107 (50.2) |
GOLD III | 52 (24.4) |
GOLD IV | 25 (11.8) |
Group A | 112 (52.6) |
Group B | 39 (18.3) |
Group C | 21 (9.9) |
Group D | 41 (19.2) |
Treatment, n (%) | |
LABA + LAMA + ICS | 66 (30.99) |
LABA + LAMA | 76 (35.68) |
LABA + ICS | 18 (8.45) |
LAMA + ICS | 1 (0.47) |
LAMA only | 36 (16.9) |
LABA only | 12 (5.63) |
No inhaler treatment | 4 (1.88) |
ACO, n (%) | 19 (8.92) |
Exacerbations per year; median (IQR) | 1 (0–1) |